Materials DTNB, guanidine-HCl, ampicillin (sodium salt), isopropyl !-D-1-thiogalactopyranoside (IPTG), and dithiothreitol (DTT) were from Research Products International (Mount Prospect, IL). Enterokinase was from EMD Chemicals (Gibbstown, New Jersey). 6-carboxyfluorescein-dArU(dA) 2 -6-tetramethylrhodamine was from Integrated DNA Technology (Coralville, IA). All other reagents, including subtilisin A (type VIII from bacillus licheniformis), RNase S, and RNase A were from Sigma-Aldrich (St. Louis, MO) and were used without further purification. Total yeast RNA was from Boehringer Mannheim (Damstadt, Germany).
grown at 37 °C with shaking in Terrific Broth containing ampicillin (400 "g/mL) until OD = 1.8-2.2 at 600 nm. Gene expression was induced by the addition of IPTG (0.5 mM). After 3-4 h, cells were harvested by centrifugation and lysed with a French pressure cell. Inclusion bodies were recovered after centrifugation and solubilized for 2 h at room temperature with denaturing solution (20 mM Tris-HCl buffer, pH 8.0, containing 7 M guanidine-HCl, 0.10 M DTT, and 10 mM EDTA). Solubilized inclusion bodies were then diluted 10-fold with 20 mM HOAc. The precipitate was removed by centrifugation, and the solution was dialyzed overnight against 20 mM HOAc at 4 °C. After removal of further precipitate, the ribonuclease solution was added dropwise to refolding buffer (0.10 M Tris-HCl buffer, pH 7.8, containing 0.5 M L-arginine-HCl, 1.0 mM reduced glutathione, and 0.2 mM oxidized glutathione). After >3 days at 4 °C, the solution was adjusted to pH 5, and concentrated using an Amicon YM10 membrane (Millipore, Billerica, MA). A 10-mL sample was applied to a G75 gel filtration FPLC column (AmershamPharmacia). The major peak after isocratic elution (50 mM sodium acetate buffer, pH 5.0, containing 0.10 M NaCl, 10 mM EDTA, and 0.02% w/v NaN 3 ) was collected and applied to a Mono S cation-exchange FPLC column (Amersham-Pharmacia). Ribonucleases were eluted with a linear gradient of NaCl (0-0.40 M) in 50 mM NaOAc buffer, pH 5.0, containing EDTA (10 mM). Protein concentrations were determined by absorbance at 278 nm using ! = 0.72 mg -1 #mL#cm -1 . 3 The identity of each variant was verified by MALDI-TOF mass spectrometry.
Protection of H12A/DDDDK/V118C RNase A with DTNB
After cation-exchange chromatography, the fractions that contained H12A/DDDDK/V118C RNase A were combined, and the pH of the resulting solution was increased by adding (to 8% v/v) 1.0 M Tris-HCl buffer, pH 8.3, containing EDTA (10 mM). To this solution was added 50 mM Tris-HCl buffer, pH 8.0, containing DTNB (5 mM) and EDTA (50 mM) such that the DTNB was in 4-fold molar excess to the protein. After incubation for 10 min, the solution was dialyzed overnight at 4 °C against 20 mM TrisHCl buffer, pH 7.4, containing NaCl (50 mM).
Synthesis, activation with DTNB, and purification of peptides S15 (KETAAAKFERQHMDS) and A4C S15 (KETCAAKFERQHMDS) were synthesized on a 50-"mol scale by standard fluorenylmethoxycarbonyl chemistry using HATU activation and a Fmoc-Ser(tBu) Wang resin (EMD Biocsciences, La Jolla, CA). Peptides were deprotected and cleaved from the resin with 4 mL of 92.5:5:2.5 trifluoroacetic acid (TFA)/thioanisole/ethanedithiol for 4 h. Peptides were then precipitated with tert-butyl methyl ether and dried under vacuum. S15 and A4C S15 were purified by reversed-phase HPLC on a C-18 semipreparative column. TFA (0.1%) was included as an ionpairing agent in HPLC solvents. Peptides were eluted with a linear gradient of acetonitrile (10-30% v/v). One-quarter volume 0.10 M Tris-HCl buffer, pH 8.0, containing DTNB (5 mM) was added to fractions containing A4C S-peptide. The solvent was then removed under reduced pressure. NTB-activated A4C S-peptide was then purified again under the same HPLC conditions. The mass of purified peptides was confirmed by MALDI-TOF mass spectrometry.
Digestion of RNase A with subtilisin
Subtilisin (5 "g) was added to a solution of RNase A (0.5 mg, 88 "L) in phosphate-buffered saline (PBS) and incubated at 4 °C. Aliquots were removed over 24 h and subjected to SDS-PAGE (15% w/v acrylamide).
Digestion of ribonucleases with enterokinase
CaCl 2 (2 mM final concentration) was added to RNase A and its DDDDK and H12A/DDDDK/V118C variants (~5 mL of a 0.85 mg/mL solution) that had been dialyzed against 20 mM Tris-HCl buffer, pH 7.4, containing NaCl (50 mM). Enterokinase (5 "L, 5 U) was added, and the reaction mixture was incubated at room temperature. Aliquots were removed over 24 h and subjected to SDS-PAGE.
Separation of S-peptide and S-protein components
The S-peptide and S-protein fragment from the enterokinase-digestion of the DDDDK and H12A/DDDDK/V118C variants of RNase A were separated by analytical or semi-preparative reverse-phase HPLC with a C-18 column and two-step linear gradient (
Step 1: 20-50% B over 3 min.
Step 2: 50-100% B over 25 min. A: 50 mM sodium phosphate buffer, pH 2.7. B: 40% A + 60% acetonitrile). 4 Fractions containing S-protein were pooled and dialyzed overnight against PBS at 4 °C. The concentration of S-protein was determined by absorbance at 280 nm using ! = 9055 M -1 #cm -1 . 5 The identity of each peak on the HPLC trace was confirmed by MALDI-TOF mass spectrometry.
Fragment complementation
To V118C S-protein (100 "L of a 1.76 mg/mL solution) was added 1.0 M Tris-HCl buffer, pH 8.0, containing EDTA (10 mM) (8 "L), and DTT (25 mM) (2 "L). After 2 min, the mixture was desalted with a Zeba Spin column, 7K MWCO (Pierce, Rockford, IL). To the collection tube was added S15 or NTB-activated A4C S15 (4 "L of 20 mg/mL). After ~10 min, the reactions were desalted again with the spin columns. SDS-PAGE and MALDI-TOF mass spectrometry confirmed the covalent linkage between A4C S15 and V118C S-protein (m/z 13324; expected: 13317).
Zymogram electrophoresis
The potassium salt of poly(cytidylic acid) (final concentration: 0.5 mg/mL) was included during the casting of a 15% w/v polyacrylamide gel. Laemmli buffer (no reducing agent) was added to each sample (2 ng). After SDS-PAGE, the gel was washed with isopropanol (20% v/v) in 10 mM Tris-HCl buffer, pH 7.0 (2$), 10 mM Tris-HCl buffer, pH 7.0 (2$), and 0.10 M Tris-HCl buffer, pH 7.5 (1$) for 10 min each. The gel was then stained for 10 min with 10 mM Tris-HCl buffer, pH 7.5, containing toluidine blue (0.02% w/v). The stained gel was rinsed several times in water, and soaked in water overnight.
Assays of ribonucleolytic activity
Initial velocities for catalysis of RNA cleavage were determined at high and low concentrations of RNase A, RNase S, and RNase-S in 50 mM NaOAc buffer, pH 6.0, containing NaCl (0.10 M). To avoid the contamination apparent in commercial preparations of RNase S ( Figure 5 , lane 6), the noncovalent complex assayed here was that of S15 and the deprotected S-protein derived from H12A/DDDDK/V118 RNase A. A fluorogenic ribonuclease substrate, 6-carboxyfluorescein-dArU(dA) 2 -6-tetramethylrhodamine, 6 was used for assays at low ribonuclease concentration. Briefly, a ribonuclease (50 "L of a 50 pM solution) was equilibrated at 37 °C in a 96-well plate. To each sample was added 6-carboxyfluorescein-dArU(dA) 2 -6-tetramethylrhodamine (50 "L of a 100 nM solution in sample buffer). Reaction progress was monitored at 37 °C by the increase in fluorescence emission at 515 nm upon excitation at 493 nm over 5 min.
